Q3 2023 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2023-11-14 · accession 0001013594-23-000924
$224.4M
Reported value
31
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 816850101 | SMTC | SEMTECH CORP | $64.4M | 28.7% | 2,500,000 | CALL | SOLE |
| 816850101 | SMTC | SEMTECH CORP | $63.2M | 28.1% | 2,452,855 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $29.2M | 13.0% | 165,000 | PUT | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TRUST | $21.4M | 9.52% | 50,000 | PUT | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $17.3M | 7.70% | 2,145,337 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $4.8M | 2.14% | 1,176,667 | Common | SOLE |
| 12122L101 | 0LS | BURGERFI INTERNATIONAL INC | $3.2M | 1.42% | 2,745,938 | Common | SOLE |
| 07134L107 | BATL | BATTALION OIL CORPORATION | $2.4M | 1.05% | 380,891 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $2.3M | 1.01% | 130,691 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.8M | 0.79% | 70,335 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $1.6M | 0.73% | 691,803 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $1.6M | 0.72% | 531,256 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $1.4M | 0.62% | 450,207 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $1.2M | 0.55% | 82,425 | Common | SOLE |
| 266605500 | DC8A | DURECT CORP | $1.1M | 0.47% | 427,455 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $853,200 | 0.38% | 27,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $826,100 | 0.37% | 110,000 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $824,000 | 0.37% | 80,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $793,901 | 0.35% | 115,898 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $697,320 | 0.31% | 78,000 | Common | SOLE |
| 44486Q103 | HUMA | HUMACYTE INC | $688,550 | 0.31% | 235,000 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $647,930 | 0.29% | 1,000,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $598,850 | 0.27% | 35,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $500,940 | 0.22% | 34,500 | Common | SOLE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $398,927 | 0.18% | 82,423 | Common | SOLE |
| 41358P205 | HARPUSD | HARPOON THERAPEUTICS INC | $332,306 | 0.15% | 82,458 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $299,620 | 0.13% | 90,794 | Common | SOLE |
| 12122L119 | — | BURGERFI INTERNATIONAL INC | $235,428 | 0.10% | 2,083,438 | CALL | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $31,575 | 0.01% | 100 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $13,185 | 0.01% | 100 | Common | SOLE |
| 166764100 | CVX | CHEVRON CORP NEW | $7,757 | 0.00% | 46 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.